登录 注册 会员服务 联系我们

The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration

  • Published:2013-10 Issue:2 Volume:171 Page:216-224
  • ISSN:0168-3659
  • Container-title:Journal of Controlled Release
  • language:en
  • Short-container-title:Journal of Controlled Release

Author:

Nakamura Takashi,Yamazaki Daiki,Yamauchi Jun,Harashima Hideyoshi

Funder

Grant-in-aid for Scientific Research

Grant-in-Aid for Young Scientists

Ministry of Education, Culture, Sports, Science and Technology of Japan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference42 articles.

1. The NKT cell system: bridging innate and acquired immunity;Taniguchi;Nat. Immunol.,2003

2. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides;Kawano;Science,1997

3. Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells;Exley;J. Exp. Med.,1997

4. Harnessing invariant NKT cells in vaccination strategies;Cerundolo;Nat. Rev. Immunol.,2009

5. KRN7000, a novel immunomodulator, and its antitumor activities;Kobayashi;Oncol. Res.,1995
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3